Analysis of Global Burden of Disease 2023 data across G20 nations spanning 1990–2023 finds that dietary risks account for 40% of colorectal cancer (CRC) deaths and 39% of disability-adjusted life years lost — making them the single largest modifiable driver by a wide margin. High fasting plasma glucose, elevated BMI, and low physical activity each contribute roughly 7–8%, with tobacco and alcohol adding 5% apiece. Despite a modest decline in age-standardized incidence (27.15 to 26.49 per 100,000; EAPC: −0.27), Bayesian projections forecast a sharp rise to 35.10 per 100,000 by 2030. Rapidly industrializing nations like Saudi Arabia (EAPC: +3.33) and South Korea (EAPC: +1.71) show alarming acceleration.
The practical takeaway here is unusually direct: four of the top six risk factors — diet quality, blood glucose control, body weight, and physical activity — are things individuals can meaningfully address without a prescription. Together they account for roughly 62% of attributable CRC mortality. This reinforces the long-standing but underappreciated case that colorectal cancer is substantially a lifestyle disease. The study's observational, ecological design limits causal inference at the individual level, and GBD attribution models carry their own uncertainty. Still, the scale of the dataset (33 years, 20 major economies) lends considerable weight to the directional conclusions. For adults, the evidence continues to converge: a fiber-rich diet, healthy weight, blood sugar management, and regular exercise are the primary levers against a cancer whose global burden is set to worsen considerably this decade.